Vemlidy, Filmtabletten

7680661900012 CH-66190 Filmtabletten
Vemlidy, Filmtabletten
Vemlidy, Filmtabletten
Vemlidy, Filmtabletten
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
25/04/2024
Patient information leaflet
Français
25/04/2024
Patient information leaflet
Italien
25/04/2024
Summary of Product Characteristics
Allemand
25/04/2024
Summary of Product Characteristics
Français
25/04/2024
Summary of Product Characteristics
Italien
25/04/2024

Detailed composition

Substance Quantity Type Category
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
94.96 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
1.331 MG Substance HBESI

Reimbursement information

Public price
CHF 504.85
Specialties list
Yes
Generic
No
SL addition date: 01/08/2017

Authorization holder

Gilead Sciences Switzerland Sàrl

6300 Zug

Authorization information

Swissmedic authorization number
66190
Drug name
Vemlidy, Filmtabletten
Galenic form
FILM
ATC Code
J05AF
Authorization status
Z
Dispensing category
A
First authorization
13/07/2017
Authorization expiration date
31/12/9999
IT Number
08.03.0.
Domain
Human medicine
Field of application
Chronische Hepatitis B

Package details

Description (FR)
VEMLIDY cpr pell 25 mg bte 30 pce
Description (DE)
VEMLIDY Filmtabl 25 mg Ds 30 Stk
Market launch
13/07/2017
Narcotic (BTM)
No